Heparin-induced thrombocytopenia is one of the most difficult problems facing clinicians today. Despite recent understanding of the pathophysiology of this disorder, there are many unresolved issues about diagnosis, prevention, and treatment. In this article, difficulties physicians encounter when faced with a suspected heparin-induced thrombocytopenia patient will be reviewed as well as our experience in 113 patients with heparin-induced thrombocytopenia which highlights the failure of current preventive strategies for heparin-induced thrombocytopenia. The experience of using warfarin in 51 patients with heparin-induced thrombocytopenia will also be reviewed.
WarkentinTEHaywardCPMBoshkovLK, Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopeniaBlood1994;84:3691.
WarkentinTELevineMNHirshJ, Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparinN Engl J Med1995;332:1330.
5.
BriegerDBMakKCatch-MarchantK, Heparin-induced thrombocytopeniaJ Am Coll Cardiol1998;31:1449.
6.
WarkentinTEChongBHGreinacherA, Heparin-induced thrombocytopenia: Towards consensusThromb Haemost1998;79:1.
KeltonJGWarkentinTE, Diagnosis of heparin-induced thrombocytopenia. Still a journey, not a destinationAm J Clin Pathol1995;104:611.
9.
Hach-WunderleVKainerIKrugB, Heparin-associated thrombosis despite normal platelet countsLancet1994;344:469.
10.
WalengaJMJeskeWPWoodJJ, Laboratory tests for heparin-induced thrombocytopenia: A multicenter studySemin Hemalot1999;36(Suppl 1):22.
11.
RamaBNHaakeREBanderSJ, Heparin-flush associated thrombocytopenia-induced hemorrhage: A case reportNebr Med J1991;76:392.
12.
LasterJLNicholsLWKSilverD, Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodiesArch Intern Med1989;149:2285.
13.
PhelanBK, Heparin-associated thrombosis without thrombocytopeniaAnn Intern Med1983;99:637.
14.
AlmeidaJICoatsRLiemTK, Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndromeJ Vasc Surg1998;27:309.
15.
HirshJWarkentinTERaschkeR, Heparin and low-molecular-weight heparin. Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safetyChest1998;114(Suppl):489S.
16.
LasterJCikritDWalkerN, The heparin-induced thrombocytopenia syndrome: An updateSurgery1987;102:763.
17.
BaughmanRPLowerEEFlessaHC, Thrombocytopenia in the intensive care unitChest1993;104:1243.
18.
BauerTLArepallyGKonkleBA, Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgeryCirculation1997;95:1242.
19.
CumminsDHalilOAminS, Which patients undergoing cardiopulmonary bypass should be assessed for development of heparin-induced thrombocytopenia? (Letter)Thromb Haemost1995;73:890.
20.
WalengaJMLewisBEHoppensteadtDA, Management of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndromeClin Appl Thromb Hemost1997;3(Suppl 1):S53.
21.
WarkentinTEKeltonJG, A fourteen year study of heparin-induced thrombocytopeniaAm J Med1996;101:502.
22.
WallsJTCurtisJJSilverD, Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognitionAnn Thorac Surg1992;53:787.
WallisDEWorkmanDLLewisBE, Failure of early heparin cessation as treatment for heparin-induced thrombocytopeniaAm J Med1999;106:629.
25.
KitchensCS, Thrombotic storm: When thrombosis begets thrombosisAm J Med1998;104:381.
26.
KluftCVerheijenJHJieAF, The postoperative fibrinolytic shutdown: A rapidly reverting acute phase pattern for the fast-acting inhibitor or tissue-type plasminogen activator after traumaScand J Clin Lab Invest1985;45:605.
27.
BoshkovLKWarkentinTEHaywardCPM, Heparin-induced thrombocytopenia and thrombosis: Clinical and laboratory studiesBr J Haematol1993;84:322.
28.
KrishnamurtiCAlvingBM, Plasminogen activator inhibitor-1: Biochemistry and evidence for modulation of fibrinolysis in vivoSemin Thromb Hemost1992;18:67.
29.
MohiuddinSMHillemanDEDestacheCJ, Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolismAm Heart J1992;123:729.
30.
WarkentinTEElavathilLJHaywardCP, The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopeniaAnn Intern Med1997;127:804.
31.
HarrisonLJohnstonMMassicotteMP, Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapyAnn Intern Med1997;126:133.
32.
RaskobGEGeorgeJN, Thrombotic complications of antithrombotic therapy: A paradox with implications for clinical practiceAnn Intern Med1997;127:839.
33.
WallisDEQuintosRWehrmacherW, Safety of warfarin anticoagulation on patients with heparin-induced thrombocytopeniaChest1999 (in press).
34.
MagnaniHN, Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (ORG 10172)Thromb Haemost1993;70:554.
35.
HaasSWalengaJMJeskeWP, Heparin-induced thrombocytopenia: Clinical considerations of alternative anticoagulation with various glycosaminoglycans and thrombin inhibitorsClin Appl Thromb Hemost1999;5:52.
